2hjk

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2hjk.gif|left|200px]]<br />
+
[[Image:2hjk.gif|left|200px]]<br /><applet load="2hjk" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2hjk" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2hjk, resolution 1.850&Aring;" />
caption="2hjk, resolution 1.850&Aring;" />
'''Crystal Structure of HLA-B5703 and HIV-1 peptide'''<br />
'''Crystal Structure of HLA-B5703 and HIV-1 peptide'''<br />
==Overview==
==Overview==
-
HLA-B*57 is associated with slower disease progression to AIDS, and CD8+ T, cell responses to B*57-restricted epitopes are thought to contribute to, this protective effect. In this study, we evaluate the B*57-restricted p24, KAFSPEVIPMF (KF11) immune response which is immunodominant during chronic, infection. Previously, we observed that the KF11 clade variants, KGFNPEVIPMF [A2G,S4N] and KAFNPEIIMPF [S4N,V7I], sharing a position 4, mutation, are differentially recognized by KF11-specific T cells. By, combining structural and cellular studies, we now demonstrate that the, KF11 and [A2G,S4N] epitopes induce distinct functional responses in, [A2G,S4N] and KF11-specific T cells, respectively, despite minimal, structural differences between the individual B*57-peptide complexes., Recently, we also elucidated the highly distinct structure of KF11 in, complex with B*5703, and have now characterized the CD8+ T cell repertoire, recognizing this epitope. We now report striking features of TCR, conservation both in terms of TCR Valpha and Vbeta chain usage, and, throughout the hypervariable region. Collectively, our findings highlight, unusual features of the B*5701/B*5703-KF11-specific immune responses which, could influence disease progression and that might be important to, consider when designing future vaccine regimens.
+
HLA-B*57 is associated with slower disease progression to AIDS, and CD8+ T cell responses to B*57-restricted epitopes are thought to contribute to this protective effect. In this study, we evaluate the B*57-restricted p24 KAFSPEVIPMF (KF11) immune response which is immunodominant during chronic infection. Previously, we observed that the KF11 clade variants KGFNPEVIPMF [A2G,S4N] and KAFNPEIIMPF [S4N,V7I], sharing a position 4 mutation, are differentially recognized by KF11-specific T cells. By combining structural and cellular studies, we now demonstrate that the KF11 and [A2G,S4N] epitopes induce distinct functional responses in [A2G,S4N] and KF11-specific T cells, respectively, despite minimal structural differences between the individual B*57-peptide complexes. Recently, we also elucidated the highly distinct structure of KF11 in complex with B*5703, and have now characterized the CD8+ T cell repertoire recognizing this epitope. We now report striking features of TCR conservation both in terms of TCR Valpha and Vbeta chain usage, and throughout the hypervariable region. Collectively, our findings highlight unusual features of the B*5701/B*5703-KF11-specific immune responses which could influence disease progression and that might be important to consider when designing future vaccine regimens.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2HJK is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2HJK OCA].
+
2HJK is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HJK OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Beattie, T.]]
[[Category: Beattie, T.]]
-
[[Category: Bwayo, J.J.]]
+
[[Category: Bwayo, J J.]]
-
[[Category: Gillespie, G.M.A.]]
+
[[Category: Gillespie, G M.A.]]
-
[[Category: Plummer, F.A.]]
+
[[Category: Plummer, F A.]]
[[Category: Rengasamy, J.]]
[[Category: Rengasamy, J.]]
[[Category: Stewart-Jones, G.]]
[[Category: Stewart-Jones, G.]]
Line 27: Line 26:
[[Category: hla]]
[[Category: hla]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:33:19 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:42:33 2008''

Revision as of 15:42, 21 February 2008


2hjk, resolution 1.850Å

Drag the structure with the mouse to rotate

Crystal Structure of HLA-B5703 and HIV-1 peptide

Contents

Overview

HLA-B*57 is associated with slower disease progression to AIDS, and CD8+ T cell responses to B*57-restricted epitopes are thought to contribute to this protective effect. In this study, we evaluate the B*57-restricted p24 KAFSPEVIPMF (KF11) immune response which is immunodominant during chronic infection. Previously, we observed that the KF11 clade variants KGFNPEVIPMF [A2G,S4N] and KAFNPEIIMPF [S4N,V7I], sharing a position 4 mutation, are differentially recognized by KF11-specific T cells. By combining structural and cellular studies, we now demonstrate that the KF11 and [A2G,S4N] epitopes induce distinct functional responses in [A2G,S4N] and KF11-specific T cells, respectively, despite minimal structural differences between the individual B*57-peptide complexes. Recently, we also elucidated the highly distinct structure of KF11 in complex with B*5703, and have now characterized the CD8+ T cell repertoire recognizing this epitope. We now report striking features of TCR conservation both in terms of TCR Valpha and Vbeta chain usage, and throughout the hypervariable region. Collectively, our findings highlight unusual features of the B*5701/B*5703-KF11-specific immune responses which could influence disease progression and that might be important to consider when designing future vaccine regimens.

Disease

Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[142830], Hypoproteinemia, hypercatabolic OMIM:[109700], Spondyloarthropathy, susceptibility to, 1 OMIM:[142830], Stevens-Johnson syndrome, carbamazepine-induced, susceptibility to OMIM:[142830]

About this Structure

2HJK is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection., Gillespie GM, Stewart-Jones G, Rengasamy J, Beattie T, Bwayo JJ, Plummer FA, Kaul R, McMichael AJ, Easterbrook P, Dong T, Jones EY, Rowland-Jones SL, J Immunol. 2006 Sep 15;177(6):3893-902. PMID:16951352

Page seeded by OCA on Thu Feb 21 17:42:33 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools